Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance  COVID-19 status Phase of research How it helps Latest publication
2-[(4,6-diaminopyrimidin-2-yl)sulfanyl]-N-(4-fluorophenyl)acetamide
Potential treatment - theoretical effect Experimental Antiviral Aug/12/2020
2-[[(2R,5R)-5-[(6R)-6-Hydroxy-5-oxo-3,3a,6,6a-tetrahydro-2H-furo[3,2-b]furan-2-yl]oxan-2-yl]-methoxyamino]-N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide
Potential treatment - theoretical effect Experimental Antiviral Mar/05/2021
2-{3-[3-Chloro-5-(cyclopropylmethoxy)phenyl]-2-oxo[2H-[1,3'-bipyridine]]-5-yl}benzonitrile
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/22/2021
2.4.1.5. 1-[2-(2‑hydroxy-3‑methoxy-5-(4-carboxyphenylazo) benzaldeneamino)ethyl]−3-methyl-3H-imidazole-3-ium hexafluorophosphate
Potential treatment - theoretical effect Experimental Antiviral Sep/18/2020
2’-O-methyl UTP
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/25/2020
2′-C-methylguanosine
Potential treatment - theoretical effect Experimental Antiviral Oct/29/2020
3,3'-(Biphenyl-4,4'-diyldidiazene-2,1-diyl)bis(4-aminonaphthalene-1-sulfonic acid)
Potential treatment - theoretical effect Experimental Antiviral Mar/26/2021
3,3-Dimethyl-N-[4-(piperidin-1-ylcarbonyl)phenyl]butanamide
Potential treatment - theoretical effect Experimental Antiviral Dec/01/2020
3-amino-N-(naphthalene-1-yl)-5-trifluoromethyl)benzamide
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/02/2021
3-{[(1R)-1-Benzyl-2-sulfanylethyl]amino}-3-oxopropanoic acid
Potential treatment - theoretical effect Experimental Antiviral Sep/08/2020
3CLpro inhibitor 6e
Potential treatment - pre-clinical evidence Experimental Antiviral Aug/03/2020
3CLpro inhibitor 6j
Potential treatment - pre-clinical evidence Experimental Antiviral Aug/03/2020
3′-O-methyl UTP
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/25/2020
4'-Acetamido-4-dimethylaminochalcone
Potential treatment - theoretical effect Experimental Antiviral Dec/26/2020
4'-Acetamidochalcone
Potential treatment - theoretical effect Experimental Antiviral Dec/26/2020
4-Chloro-N-(1-methyl-1H-benzimidazol-5-yl)benzamide
Potential treatment - theoretical effect Experimental Antiviral Nov/23/2020
4-Chloro-N-[1-(2-quinolin-3-ylethynyl)cyclohexyl]-1H-pyrazole-5-carboxamide
Potential treatment - theoretical effect Experimental Antiviral Sep/21/2020
4-[(pyridin-3-ylmethyl) amino]-2H-chromen-2-one
Potential treatment - theoretical effect Experimental Antiviral Jul/16/2020
4-[2-(2-Benzyloxycarbonylamino-3-t-butoxy-butyrylamino)-4-methyl-pentanoylamino]-5-(2-oxo-pyrrolidin-3-yl)-pent-2-enoic acid ethyl ester
Potential treatment - pre-clinical evidence Experimental Antiviral Apr/28/2021
4-{[5-(2-Nitrophenyl)-2-furyl] methylene}-3-phenyl-5(4H)-isoxazolone
Potential treatment - theoretical effect Experimental Antiviral Nov/23/2020